↓ Skip to main content

Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studies

Overview of attention for article published in Investigational New Drugs, June 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
3 patents

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
20 Mendeley
Title
Inhibition of cancer growth and induction of apoptosis by BGP-13 and BGP-15, new calcipotriene-derived vitamin D3 analogs, in-vitro and in-vivo studies
Published in
Investigational New Drugs, June 2012
DOI 10.1007/s10637-012-9839-1
Pubmed ID
Authors

Amnon C. Sintov, Liron Berkovich, Shimon Ben-Shabat

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 20%
Researcher 4 20%
Student > Ph. D. Student 4 20%
Professor > Associate Professor 2 10%
Student > Master 2 10%
Other 1 5%
Unknown 3 15%
Readers by discipline Count As %
Medicine and Dentistry 7 35%
Biochemistry, Genetics and Molecular Biology 3 15%
Agricultural and Biological Sciences 2 10%
Computer Science 1 5%
Physics and Astronomy 1 5%
Other 1 5%
Unknown 5 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2023.
All research outputs
#7,755,938
of 23,575,882 outputs
Outputs from Investigational New Drugs
#343
of 1,197 outputs
Outputs of similar age
#55,660
of 166,512 outputs
Outputs of similar age from Investigational New Drugs
#4
of 17 outputs
Altmetric has tracked 23,575,882 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,197 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,512 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.